JP2016501226A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016501226A5 JP2016501226A5 JP2015545408A JP2015545408A JP2016501226A5 JP 2016501226 A5 JP2016501226 A5 JP 2016501226A5 JP 2015545408 A JP2015545408 A JP 2015545408A JP 2015545408 A JP2015545408 A JP 2015545408A JP 2016501226 A5 JP2016501226 A5 JP 2016501226A5
- Authority
- JP
- Japan
- Prior art keywords
- enteric
- group
- sodium
- povidone
- microcrystalline cellulose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MX2012014071A MX350569B (es) | 2012-12-03 | 2012-12-03 | Composicion farmaceutica estable para el tratamiento de osteoporosis. |
| MXMX/A/2012/014071 | 2012-12-03 | ||
| PCT/MX2013/000130 WO2014088385A1 (es) | 2012-12-03 | 2013-10-30 | Composición farmacéutica estable para el tratamiento de osteoporosis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016501226A JP2016501226A (ja) | 2016-01-18 |
| JP2016501226A5 true JP2016501226A5 (enExample) | 2018-07-19 |
| JP6374879B2 JP6374879B2 (ja) | 2018-08-15 |
Family
ID=50883732
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015545408A Expired - Fee Related JP6374879B2 (ja) | 2012-12-03 | 2013-10-30 | 骨粗しょう症治療用の安定な医薬組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20150342968A1 (enExample) |
| EP (1) | EP2926817B1 (enExample) |
| JP (1) | JP6374879B2 (enExample) |
| ES (1) | ES2629739T3 (enExample) |
| MX (1) | MX350569B (enExample) |
| WO (1) | WO2014088385A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20160074515A1 (en) | 2014-06-20 | 2016-03-17 | Reform Biologics, Llc | Viscosity-reducing excipient compounds for protein formulations |
| US10478498B2 (en) | 2014-06-20 | 2019-11-19 | Reform Biologics, Llc | Excipient compounds for biopolymer formulations |
| EP4210757A4 (en) * | 2020-09-11 | 2024-10-23 | Comera Life Sciences, Inc. | EXCELLENT COMPOUNDS FOR PROTEIN FORMULATIONS |
| CN119385959B (zh) * | 2025-01-03 | 2025-04-01 | 山东第一医科大学附属省立医院(山东省立医院) | 一种利塞膦酸钠片剂及其制备方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA04004807A (es) | 2004-05-19 | 2005-11-24 | Merck & Co Inc | Composiciones y metodos para inhibir la resorcion osea. |
| US7645459B2 (en) * | 2004-05-24 | 2010-01-12 | The Procter & Gamble Company | Dosage forms of bisphosphonates |
| US7645460B2 (en) * | 2004-05-24 | 2010-01-12 | The Procter & Gamble Company | Dosage forms of risedronate |
| US7473684B2 (en) | 2005-09-16 | 2009-01-06 | Selamine Limited | Bisphosphonate formulation |
| KR100822133B1 (ko) | 2006-11-06 | 2008-04-15 | 한미약품 주식회사 | 비타민 ｄ 또는 이의 유도체의 고체분산체 및비스포스포네이트를 포함하는, 골다공증 예방 또는 치료용복합제제 |
| JP2010513475A (ja) * | 2006-12-20 | 2010-04-30 | ランドシュタイナー サイエンティフィック エッセ アー デ シー ヴイ | リセドロネートおよびビタミンｄ組成物 |
| KR100844256B1 (ko) * | 2007-03-23 | 2008-07-07 | 코오롱제약주식회사 | 리세드로네이트와 비타민 ｄ를 포함하는 대사성 골질환치료용 약제조성물 및 이의 제조방법 |
| EP2201937A1 (en) * | 2008-12-23 | 2010-06-30 | Teva Pharmaceutical Industries Ltd. | Formulations comprising vitamin D or derivatives thereof |
| TR200900878A2 (tr) | 2009-02-05 | 2010-08-23 | Bi̇lgi̇ç Mahmut | Tek bir dozaj formunda kombine edilen farmasötik formülasyonlar |
| KR101102364B1 (ko) * | 2009-09-18 | 2012-01-03 | 한림제약(주) | 비스포스포네이트 유도체 및 고용량의 콜레칼시페롤을 포함하는 약학 조성물 |
| KR20120005228A (ko) * | 2010-07-08 | 2012-01-16 | 주식회사 네비팜 | 골다공증 치료용 비스포스폰산 함유 장용 약학조성물 및 그의 제조방법 |
-
2012
- 2012-12-03 MX MX2012014071A patent/MX350569B/es active IP Right Grant
-
2013
- 2013-10-30 ES ES13859631.7T patent/ES2629739T3/es active Active
- 2013-10-30 WO PCT/MX2013/000130 patent/WO2014088385A1/es not_active Ceased
- 2013-10-30 EP EP13859631.7A patent/EP2926817B1/en active Active
- 2013-10-30 JP JP2015545408A patent/JP6374879B2/ja not_active Expired - Fee Related
- 2013-10-30 US US14/647,981 patent/US20150342968A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6150777B2 (ja) | 固体薬学的組成物およびそれらの生産のためのプロセス | |
| JP6030643B2 (ja) | ガン細胞の増殖を阻害するアミド誘導体および非金属塩滑沢剤を含む医薬組成物 | |
| CN103458880A (zh) | 口服给药的单位剂型 | |
| US9770437B2 (en) | Compositions of eltrombopag | |
| JP7482182B2 (ja) | プロトンポンプ阻害剤を含む経口用固形製剤組成物、それを含む経口用固形製剤及びその製造方法 | |
| RU2016102605A (ru) | Фармацевтический комбинированный состав капсулы, содержащий тадалафил и тамсулозин | |
| KR20150118160A (ko) | 장용정 | |
| AU2016231883A1 (en) | Pharmaceutical compositions of dimethyl fumarate | |
| JP2019513801A (ja) | ニコチンアミドの経口薬学的組成物 | |
| JP2019513801A5 (enExample) | ||
| WO2015085739A1 (zh) | 一种多层固体药物剂型 | |
| JP2015221782A (ja) | モンテルカストナトリウム含有製剤 | |
| CN108430462B (zh) | 包括富马酸二甲酯的肠溶包衣口服药物制剂 | |
| KR101845665B1 (ko) | 프로톤 펌프 저해제를 포함하는 경구용 고형제제 조성물, 이를 포함하는 경구용 고형제제 및 그 제조방법 | |
| WO2016113754A2 (en) | Novel oral dosage forms of dimethyl fumarate | |
| CN112533608B (zh) | 包含1,3,5-三嗪衍生物或其盐的固体药物组合物 | |
| CA2988267A1 (en) | Extended release capecitabine capsules | |
| JP2019034929A (ja) | エソメプラゾールマグネシウム水和物を含有する腸溶性コーティング製剤、およびその製造方法 | |
| JP2020090456A (ja) | エルロチニブを有効成分とする医薬錠剤 | |
| JP2020075924A (ja) | エルロチニブを有効成分とする医薬錠剤 | |
| WO2017056107A1 (en) | Pharmaceutical compositions of dimethyl fumarate | |
| WO2013088272A1 (en) | Pharmaceutical composition comprising esomeprazole magnesium dihydrate | |
| WO2015114509A1 (en) | Stabilized gastroretentive tablets of pregabalin | |
| TR2023003089T2 (tr) | Mesalami̇n ve i̇lgi̇li̇ eksi̇pi̇yanlari i̇çeren farmasöti̇k kompozi̇syonlar | |
| CH699302B1 (de) | Orale pharmazeutische Formulierung für Omeprazol, enthaltend eine spezifische Trennschicht. |